Streetbeat News

RBGPF

Reckitt Benckiser Group Plc

https://www.rb.com

CEO

Laxman Narasimhan

Industry

Soap and Other Detergent Manufacturing

Open

68.00

Mkt cap

47B

Volume

700

High

69.02

P/E Ratio

25.95

52-wk high

70.21

Low

68.00

Div yield

0.04

52-wk low

50.76

Reckitt Benckiser Group plc (RBGPF) held its Q4 2024 earnings call, discussing the company's financial performance and outlook. Key participants included the CEO, CFO, and various analysts from major financial institutions.

Portfolio Pulse from

March 07, 2025 | 3:30 pm

Reckitt Benckiser is exploring the sale of its homecare division and evaluating options for its Mead Johnson Nutrition business. The company aims to focus on its top-performing brands and optimize shareholder returns. Goldman Sachs is assisting in the evaluation process.

Portfolio Pulse from Vandana Singh

September 18, 2024 | 1:38 pm

An Illinois jury has ordered Reckitt Benckiser's Mead Johnson to pay $60 million for a case involving its Enfamil baby formula and the death of a premature infant from NEC. This opens the door to hundreds of similar lawsuits against Mead Johnson and Abbott Laboratories. Over 400 NEC lawsuits are pending, separate from other legal issues Abbott faces. ABT shares fell 4.59% to $113.40.

Portfolio Pulse from Vandana Singh

March 15, 2024 | 5:48 pm

Reckitt Benckiser Group, owner of the Durex brand, is tapping into China's livestreaming trend to sell condoms, aiming to expand its share in the $5 billion-plus Chinese condom market. Despite the challenges posed by strict regulatory oversight on sex-related content, Reckitt sees significant potential in livestreaming, having already found success with household products. The move comes as China's aging population and demographic shifts highlight the growing importance of healthcare and wellness industries, with Reckitt holding a 40% market share in China's condom market as of 2020.

Portfolio Pulse from Benzinga Neuro

February 29, 2024 | 7:54 am

An FDA panel has unanimously voted against the effectiveness of phenylephrine, a drug ingredient used in several leading decongestants. If the FDA follows the panel's recommendations, companies like Johnson & Johnson, Kenvue Inc, Bayer AG, GSK Plc's Haleon Plc, Procter & Gamble Company, Reckitt Benckiser Group and others may have to pull their oral medications containing phenylephrine from store shelves. This could also impact pharmacy retailers like CVS Health Inc, Walgreens Boots Alliance Inc, and Rite Aid Corp.

Portfolio Pulse from Vandana Singh

September 12, 2023 | 8:06 pm

The Federal Trade Commission (FTC) is investigating potential collusion among baby-formula manufacturers, including Abbott Laboratories, Nestlé, and Reckitt Benckiser Group, in bidding for state contracts. The FTC is also examining the broader impact of this coordination on sales outside the Women, Infants, and Children (WIC) formula-supply program.

Portfolio Pulse from Vandana Singh

May 24, 2023 | 12:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.